The effects of the coronavirus disease pandemic on intravenous thrombolytic therapy among patients with acute ischemic stroke in Dalian, China

Abstract Background We investigated the influence of the coronavirus disease 2019 (COVID-19) pandemic on the number of patients with acute ischemic stroke who received intravenous thrombolytic therapy (ITT) in Dalian, China, in 2020. Methods This retrospective descriptive study, conducted from Febru...

Full description

Bibliographic Details
Main Authors: Xin Pan, Shubei Ma, Xiaowen Sui, Lili Xie, Furong Li, Zhengping Cheng, Li Cui, Hongling Zhao
Format: Article
Language:English
Published: BMC 2023-01-01
Series:BMC Neurology
Subjects:
Online Access:https://doi.org/10.1186/s12883-023-03053-5
_version_ 1797952486564167680
author Xin Pan
Shubei Ma
Xiaowen Sui
Lili Xie
Furong Li
Zhengping Cheng
Li Cui
Hongling Zhao
author_facet Xin Pan
Shubei Ma
Xiaowen Sui
Lili Xie
Furong Li
Zhengping Cheng
Li Cui
Hongling Zhao
author_sort Xin Pan
collection DOAJ
description Abstract Background We investigated the influence of the coronavirus disease 2019 (COVID-19) pandemic on the number of patients with acute ischemic stroke who received intravenous thrombolytic therapy (ITT) in Dalian, China, in 2020. Methods This retrospective descriptive study, conducted from February 1, 2020, to August 31, 2020, examined 13 hospitals in Dalian that participated in the “stroke emergency map”. To use this “stroke emergency map” of China, patients followed the official “Stroke Map” WeChat account and dialed 120 for emergency medical services. We analyzed the number of patients with acute ischemic stroke who underwent ITT. In particular, we examined the onset-to-door time (ODT), door-to-needle time (DNT), onset-to-needle time (ONT), mode of transportation to the hospital, and National Institutes of Health Stroke Scale (NIHSS) scores before and after ITT. Data were collected for the aforementioned period and compared with the 2021 baseline data from the same time of year. The Mann‒Whitney U test was performed for data analysis. Results Compared with the data from 2020, the number of patients with acute ischemic stroke who underwent ITT increased (from 735 to 1719 cases) in 2021, but the DNT decreased (from 59 to 45 min; P = 0.002). Moreover, 83.9% of patients in 2020 presented to the hospital without ambulance transport, compared to 81.1% of patients in the 2021 non-COVID-19 pandemic period. Patients with NIHSS scores of 6–14 were more likely to call an ambulance for transport to the hospital than to transport themselves to the emergency department. Conclusions During the 2020 COVID-19 pandemic, the DNT was prolonged as a result of strengthened fever surveillance. In 2021, the number of patients with acute ischemic stroke who underwent ITT increased compared to the previous year. Notably, the growth in the number of patients with acute ischemic stroke who underwent ITT benefited from both the “stroke emergency map” of China and the “green channel,” a novel treatment approach that focuses on the rational design of the rescue process. Trial registration. Our study was a retrospective descriptive study, not a clinical trial, thus we did not have to register for clinical trials.
first_indexed 2024-04-10T22:47:06Z
format Article
id doaj.art-70936d005d754b41abecf64b7110fc4d
institution Directory Open Access Journal
issn 1471-2377
language English
last_indexed 2024-04-10T22:47:06Z
publishDate 2023-01-01
publisher BMC
record_format Article
series BMC Neurology
spelling doaj.art-70936d005d754b41abecf64b7110fc4d2023-01-15T12:15:00ZengBMCBMC Neurology1471-23772023-01-012311510.1186/s12883-023-03053-5The effects of the coronavirus disease pandemic on intravenous thrombolytic therapy among patients with acute ischemic stroke in Dalian, ChinaXin Pan0Shubei Ma1Xiaowen Sui2Lili Xie3Furong Li4Zhengping Cheng5Li Cui6Hongling Zhao7Department of Neurology, Dalian Municipal Central Hospital Affiliated With Dalian Medical UniversityDepartment of Neurology, Dalian Municipal Central Hospital Affiliated With Dalian Medical UniversityDepartment of Neurology, Dalian Municipal Central Hospital Affiliated With Dalian Medical UniversityDepartment of Neurology, Dalian Municipal Central Hospital Affiliated With Dalian Medical UniversityDepartment of Neurology, Dalian Municipal Central Hospital Affiliated With Dalian Medical UniversityDepartment of Neurology, Dalian Municipal Central Hospital Affiliated With Dalian Medical UniversityDepartment of Neurology, Dalian Municipal Central Hospital Affiliated With Dalian Medical UniversityDepartment of Neurology, Dalian Municipal Central Hospital Affiliated With Dalian Medical UniversityAbstract Background We investigated the influence of the coronavirus disease 2019 (COVID-19) pandemic on the number of patients with acute ischemic stroke who received intravenous thrombolytic therapy (ITT) in Dalian, China, in 2020. Methods This retrospective descriptive study, conducted from February 1, 2020, to August 31, 2020, examined 13 hospitals in Dalian that participated in the “stroke emergency map”. To use this “stroke emergency map” of China, patients followed the official “Stroke Map” WeChat account and dialed 120 for emergency medical services. We analyzed the number of patients with acute ischemic stroke who underwent ITT. In particular, we examined the onset-to-door time (ODT), door-to-needle time (DNT), onset-to-needle time (ONT), mode of transportation to the hospital, and National Institutes of Health Stroke Scale (NIHSS) scores before and after ITT. Data were collected for the aforementioned period and compared with the 2021 baseline data from the same time of year. The Mann‒Whitney U test was performed for data analysis. Results Compared with the data from 2020, the number of patients with acute ischemic stroke who underwent ITT increased (from 735 to 1719 cases) in 2021, but the DNT decreased (from 59 to 45 min; P = 0.002). Moreover, 83.9% of patients in 2020 presented to the hospital without ambulance transport, compared to 81.1% of patients in the 2021 non-COVID-19 pandemic period. Patients with NIHSS scores of 6–14 were more likely to call an ambulance for transport to the hospital than to transport themselves to the emergency department. Conclusions During the 2020 COVID-19 pandemic, the DNT was prolonged as a result of strengthened fever surveillance. In 2021, the number of patients with acute ischemic stroke who underwent ITT increased compared to the previous year. Notably, the growth in the number of patients with acute ischemic stroke who underwent ITT benefited from both the “stroke emergency map” of China and the “green channel,” a novel treatment approach that focuses on the rational design of the rescue process. Trial registration. Our study was a retrospective descriptive study, not a clinical trial, thus we did not have to register for clinical trials.https://doi.org/10.1186/s12883-023-03053-5Acute ischemic strokeCOVID-19Intravenous thrombolytic therapyStroke emergency mapsGreen channel
spellingShingle Xin Pan
Shubei Ma
Xiaowen Sui
Lili Xie
Furong Li
Zhengping Cheng
Li Cui
Hongling Zhao
The effects of the coronavirus disease pandemic on intravenous thrombolytic therapy among patients with acute ischemic stroke in Dalian, China
BMC Neurology
Acute ischemic stroke
COVID-19
Intravenous thrombolytic therapy
Stroke emergency maps
Green channel
title The effects of the coronavirus disease pandemic on intravenous thrombolytic therapy among patients with acute ischemic stroke in Dalian, China
title_full The effects of the coronavirus disease pandemic on intravenous thrombolytic therapy among patients with acute ischemic stroke in Dalian, China
title_fullStr The effects of the coronavirus disease pandemic on intravenous thrombolytic therapy among patients with acute ischemic stroke in Dalian, China
title_full_unstemmed The effects of the coronavirus disease pandemic on intravenous thrombolytic therapy among patients with acute ischemic stroke in Dalian, China
title_short The effects of the coronavirus disease pandemic on intravenous thrombolytic therapy among patients with acute ischemic stroke in Dalian, China
title_sort effects of the coronavirus disease pandemic on intravenous thrombolytic therapy among patients with acute ischemic stroke in dalian china
topic Acute ischemic stroke
COVID-19
Intravenous thrombolytic therapy
Stroke emergency maps
Green channel
url https://doi.org/10.1186/s12883-023-03053-5
work_keys_str_mv AT xinpan theeffectsofthecoronavirusdiseasepandemiconintravenousthrombolytictherapyamongpatientswithacuteischemicstrokeindalianchina
AT shubeima theeffectsofthecoronavirusdiseasepandemiconintravenousthrombolytictherapyamongpatientswithacuteischemicstrokeindalianchina
AT xiaowensui theeffectsofthecoronavirusdiseasepandemiconintravenousthrombolytictherapyamongpatientswithacuteischemicstrokeindalianchina
AT lilixie theeffectsofthecoronavirusdiseasepandemiconintravenousthrombolytictherapyamongpatientswithacuteischemicstrokeindalianchina
AT furongli theeffectsofthecoronavirusdiseasepandemiconintravenousthrombolytictherapyamongpatientswithacuteischemicstrokeindalianchina
AT zhengpingcheng theeffectsofthecoronavirusdiseasepandemiconintravenousthrombolytictherapyamongpatientswithacuteischemicstrokeindalianchina
AT licui theeffectsofthecoronavirusdiseasepandemiconintravenousthrombolytictherapyamongpatientswithacuteischemicstrokeindalianchina
AT honglingzhao theeffectsofthecoronavirusdiseasepandemiconintravenousthrombolytictherapyamongpatientswithacuteischemicstrokeindalianchina
AT xinpan effectsofthecoronavirusdiseasepandemiconintravenousthrombolytictherapyamongpatientswithacuteischemicstrokeindalianchina
AT shubeima effectsofthecoronavirusdiseasepandemiconintravenousthrombolytictherapyamongpatientswithacuteischemicstrokeindalianchina
AT xiaowensui effectsofthecoronavirusdiseasepandemiconintravenousthrombolytictherapyamongpatientswithacuteischemicstrokeindalianchina
AT lilixie effectsofthecoronavirusdiseasepandemiconintravenousthrombolytictherapyamongpatientswithacuteischemicstrokeindalianchina
AT furongli effectsofthecoronavirusdiseasepandemiconintravenousthrombolytictherapyamongpatientswithacuteischemicstrokeindalianchina
AT zhengpingcheng effectsofthecoronavirusdiseasepandemiconintravenousthrombolytictherapyamongpatientswithacuteischemicstrokeindalianchina
AT licui effectsofthecoronavirusdiseasepandemiconintravenousthrombolytictherapyamongpatientswithacuteischemicstrokeindalianchina
AT honglingzhao effectsofthecoronavirusdiseasepandemiconintravenousthrombolytictherapyamongpatientswithacuteischemicstrokeindalianchina